Home » Topics » Regulatory » EMA

EMA
RSS

Stempeucel receives EMA advanced therapy medicinal product classification

March 24, 2015

NovImmune's HLH trial of NI-0501 allows first-line treatment after protocol amendment

March 19, 2015

ImMucin receives E.U. orphan drug designation for multiple myeloma

March 17, 2015

AOP Orphan completes enrollment in phase III trial of ropeginterferon alfa 2b

March 9, 2015

CHMP recommends approval of Humira for severe chronic plaque psoriasis in children

March 3, 2015

EMA committee recommends approval of Avastin plus chemotherapy for advanced cervical cancer

March 3, 2015

EMA accepts MAA for Santen's intravitreal sirolimus for non-infectious uveitis

March 2, 2015

Takeda withdraws new European Rienso submission

March 2, 2015

EMA committee recommends new approval of Vectibix in metastatic colorectal cancer

March 2, 2015

EMA's CHMP backs approval of Jinarc for rare kidney disease

March 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...